Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01997463 · ClinicalTrials.gov registry record · Phase 4

Supervised Asthma Medication in Schools (SAMS)

A Phase 4 study, sponsored by University of Arizona.

Completed
Registry status
Phase 4
Development phase
442
Enrollment target

NCT01997463 is a Phase 4 study that has completed, run by University of Arizona. The registered enrollment target is 442 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01997463, a Phase 4 study, has completed, sponsored by University of Arizona.

COMPLETED
Registry status
Phase 4
Development phase
442 participants
Enrollment target

Study Summary

The investigators hypothesize that school-based, direct supervision of daily controller therapy will result in more effective asthma control, as assessed by the Asthma Control Questionnaire than usual care. Additionally, as the result of enhanced asthma control and resulting decrease in health care utilization, school-based, direct supervision of daily controller therapy will result in lower cost per quality-adjusted life year (QALY) gained than usual care.

Interventions

  • DRUG Supervised asthma therapy in schools

Trial Details

FieldValue
Enrollment Target 442 participants
Start Date 2014-08
Est. Completion 2016-06
Phase Phase 4

Sponsor

University of Arizona

349 total trials

What the Registry Record Tells You About NCT01997463

The ClinicalTrials.gov registry entry for NCT01997463 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 442 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Supervised asthma therapy in schools is the first listed.

NCT01997463 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01997463 about?

NCT01997463 is a clinical study titled "Supervised Asthma Medication in Schools (SAMS)". The investigators hypothesize that school-based, direct supervision of daily controller therapy will result in more effective asthma control, as assessed by the Asthma Control Questionnaire than usual care. Additionally, as the result of enhanced asthma control and resulting decrease in health care ...

What is the current status of trial NCT01997463?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 442 participants. The study started on 2014-08. Estimated completion is 2016-06.

What interventions are being tested in trial NCT01997463?

The interventions under investigation include: Supervised asthma therapy in schools (DRUG).

Who is sponsoring clinical trial NCT01997463?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.